EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2

Genli Ma, Weiwei Huang, Hangcong Yan, Bin Shen, Shanli Zhu, Xingxing Xu iD

Cells · 24.06.2026 · 15 (13) · 1149

DOI: 10.3390/cells15131149 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, online erschienen am 24.06.2026. Verfasst von Genli Ma und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou 325035, China. Hauptthemen laut MEDLINE: Interferon Regulatory Factor-1, Glioblastoma, Cellular Senescence, 2',5'-Oligoadenylate Synthetase. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wenzhou Medical University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Glioblastoma (GBM), a highly aggressive brain tumor, is characterized by poor treatment outcomes and a strong tendency to recur after therapy. Therapy-induced senescence (TIS) of GBM cells has emerged as a key driver of GBM progression and relapse. Temozolomide (TMZ), which serves as the standard chemotherapeutic agent for GBM, is known to induce senescence; however, the molecular mechanisms underlying this process remain largely unknown. In this work, we found that interferon regulatory factor-1 (IRF1) was downregulated in TMZ-induced senescent GBM cells. Functionally, knockdown of IRF1 increased the activity of senescence-associated β-galactosidase (SA-β-gal), reduced protein expression of Lamin B1, inhibited cell division, and enhanced senescence-associated secretory phenotype (SASP) of GBM cells, indicating that downregulation of IRF1 promotes senescence of GBM cells. Conversely, overexpression of IRF1 partially reversed TMZ-induced senescence. Further exploration revealed that downregulation of IRF1 reduced the expression of 2′,5′-oligoadenylate synthetase 2 (OAS2), and overexpression of IRF1 increased the expression of OAS2. OAS2 was also downregulated in TMZ-induced senescent GBM cells, and knockdown of OAS2 induced senescence of GBM cells as well. Taken together, our study reveals that IRF1 inhibits TMZ-induced senescence of GBM cells through OAS2, highlighting a novel regulatory axis that may offer potential therapeutic targets for improving GBM treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Interferon Regulatory Factor-1GlioblastomaCellular Senescence2',5'-Oligoadenylate SynthetaseBrain NeoplasmsHumansCell Line, TumorTemozolomideGene Expression Regulation, NeoplasticDown-Regulation

Stichwörter der Autor:innen

IRF1OAS2glioblastomasenescence

Substanzen

Interferon Regulatory Factor-12',5'-Oligoadenylate SynthetaseTemozolomideIRF1 protein, human

Autor:innen und Institutionen

  • School of Basic Medical Sciences, Wenzhou Medical University, Wenzhou 325035, China.

ORCID-Profile: Xingxing Xu

Förderung

  • Wenzhou Medical University

Zitieren

APA

Ma, G., Huang, W., Yan, H., Shen, B., Zhu, S., & Xu, X. (2026). IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2. Cells, 15(13), 1149. https://doi.org/10.3390/cells15131149

Vancouver

Ma G, Huang W, Yan H, Shen B, Zhu S, Xu X. IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2. Cells. 2026;15(13):1149. doi:10.3390/cells15131149

BibTeX
@article{Ma2026,
  author = {Ma, Genli and Huang, Weiwei and Yan, Hangcong and Shen, Bin and Zhu, Shanli and Xu, Xingxing},
  title = {IRF1 Inhibits Therapy-Induced Senescence of Glioblastoma Cells Through OAS2},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {13},
  pages = {1149},
  doi = {10.3390/cells15131149}
}
Kostenlos starten →